Pallas Capital Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$929K Buy
+1,994
New +$838K 0.03% 378
2026
Q1
– Sell
-1,087
Closed -$465K – 880
2025
Q4
$465K Buy
1,087
+201
+23% +$87.5K 0.02% 555
2025
Q3
$397K Buy
886
+284
+47% +$129K 0.01% 588
2025
Q2
$293K Buy
+602
New +$343K 0.01% 664
2023
Q2
– Sell
-3,680
Closed -$2.09M – 267
2023
Q1
$2.09M Buy
3,680
+7
+0.2% +$3.57K 0.2% 96
2022
Q4
$1.83M Buy
3,673
+81
+2% +$39.4K 0.19% 98
2022
Q3
$1.73M Buy
3,592
+191
+6% +$91.8K 0.19% 96
2022
Q2
$1.72M Sell
3,401
-149
-4% -$72.7K 0.24% 77
2022
Q1
$1.77M Buy
3,550
+477
+16% +$229K 0.23% 87
2021
Q4
$1.45M Buy
3,073
+85
+3% +$40.8K 0.18% 100
2021
Q3
$1.45M Buy
2,988
+746
+33% +$352K 0.16% 113
2021
Q2
$1.06M Buy
2,242
+529
+31% +$254K 0.15% 113
2021
Q1
$839K Buy
+1,713
New +$840K 0.19% 94

Other funds holding CHE

Pallas Capital Advisors's CHE Position: Q2 2026 in Review

Pallas Capital Advisors opened a new position in Chemed (CHE) in Q2 2026: 1,994 shares worth $929K. The stake represents 0.03% of the portfolio and ranks #378 among its holdings. This is a return to the name: Pallas Capital Advisors previously reported a position in CHE as recently as Q4 2025.

Pallas Capital Advisors first reported a position in CHE in Q1 2021 and has held it in 13 quarters since. The position peaked at $2.09M in Q1 2023. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Pallas Capital Advisors held 1,994 shares of Chemed worth $929K as of Q2 2026.
  • Chemed was a new Pallas Capital Advisors position in Q2 2026.
  • Chemed made up 0.03% of Pallas Capital Advisors's portfolio in Q2 2026, its #378 holding.
  • Pallas Capital Advisors first reported a position in Chemed in Q1 2021 and has held it in 13 quarters since.
  • Pallas Capital Advisors's Chemed position peaked at $2.09M in Q1 2023.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.